News
AstraZeneca Pharma India Share Price Today (11th Jul, 2025): Check AstraZeneca Pharma India Stock Price live NSE/BSE on financialexpress.com. Get AstraZeneca Pharma India today's stock price, 52 ...
AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.
Despite a Q1 revenue miss due to currency headwinds, core EPS beat expectations for AstraZeneca. Read why AZN stock is a Buy.
Citi downgraded Man Group on Wednesday to 'neutral' from 'buy' and slashed its price target on the stock to 185.0p from ...
One of Wood's favorite AI stocks has been criticized by CNBC host Jim Cramer multiple times in 2025, including this week.
Hiroshi Watanabe/DigitalVision via Getty Images Most major stock indexes across the globe ended the week higher, following ...
The fallers board was led by WPP, which slumped by 16% to its lowest level since 2009 after the marketing and advertising ...
2d
Zacks Investment Research on MSNAstraZeneca Boasts Strong Oncology Portfolio: Can It Sustain Growth?AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...
The FTSE 100 surged to a new record high as investors were unfazed by Donald Trump’s fresh barrage of tariffs. The UK’s ...
FTSE 100 darling Rolls-Royce is on the cusp of hitting its latest impressive milestone as its shares edge closer to being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results